Home›Research›Compare›ARA-290 vs Foxo4-DRI
Peptide Comparison
ARA-290 vs Foxo4-DRI
Both are Longevity peptides.
Foxo4-DRI
Foxo4-D-Retro-Inverso
Half-life: Unknown
12 providers listed
Quick Verdict
ARA-290
Risk
Half-life
~3 hours
Foxo4-DRI
Risk
Half-life
Unknown
Side-by-Side Comparison
About ARA-290
Non-hematopoietic EPO analogue; activates innate repair receptor (IRR/EPOR/CD131 complex) without erythropoietic effects; promotes tissue repair and nerve healing
A modified erythropoietin peptide that activates tissue repair pathways without stimulating red blood cell production. Strong evidence for neuropathic pain and sarcoidosis.
Research Areas
About Foxo4-DRI
D-retro-inverso peptide that disrupts Foxo4/p53 interaction in senescent cells; restores p53-mediated apoptosis selectively in senescent cells; clears cellular "zombie cells"
A breakthrough senolytic peptide that selectively eliminates senescent cells by restoring their ability to undergo apoptosis. Produced dramatic rejuvenation effects in preclinical studies.
Research Areas
Find Providers
Where to source these peptides
Providers offering
ARA-290
12 listed
Browse directory →
Providers offering
Foxo4-DRI
12 listed
Browse directory →
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More longevity Comparisons
Browse all peptides →Educational research tools — not medical advice.